• Sonuç bulunamadı

2015 Subject Index

N/A
N/A
Protected

Academic year: 2021

Share "2015 Subject Index"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

Acute exacerbation/Akut alevlenme ... 48

Acute failure-on-chronic liver/Kronik karaciğerde akut yetmezlik... 48

Acute hepatitis B/Akut hepatit B ... 98

Acute liver failure/Akut karaciğer yetmezliği ... 98

Acute pancreatitis/Akut pankreatit ... 35

Age-specific anti-HCV/Yaş gruplarında anti-HCV ... 40

Animal models/Hayvan modelleri ... 65

Antenatal/Doğum öncesi takip ... 31

Anti HAV IgG/Anti HAV IgG ... 24

Anti HAV IgM/Anti HAV IgM ... 24

Anti-HCV/Anti-HCV ...28, 40, 76 Anti-HIV/Anti-HIV ...28, 76 Biology/Biyoloji ... 1

Biopsy/Biyopsi ... 53

Blood donors/Kan bağışçıları ... 28

Cholestasis/Kolestaz ... 98

Chronic hepatitis B/Kronik hepatit B ... 17, 35, 48, 89 Chronic hepatitis C/Kronik hepatit C ...59, 102 Chronic viral hepatitis/Kronik viral hepatit ... 9

Cirrhosis/Siroz ...89, 102 Co-infection/Koenfeksiyon ... 80

Cost savings/Maliyet tasarrufu ... 76

DNA/DNA ... 53

Drug resistance/İlaç direnci ... 85

Economic evaluation/Ekonomik değerlendirme ... 76

Fibrosis/Fibroz ...9, 80 Genotype 1b/Genotip 1b ... 13

Genotype 4/Genotip 4 ... 13

HBsAg/HBsAg ...28,76 HBV DNA/HBV DNA ...106

HBV reactivation/HBV reaktivasyonu ...106

HBV/HBV ...1, 31 HCV seroprevalence/HCV seroprevalans ... 40

HCV/HCV ...13, 31 Hepatitis A virüs/Hepatit A virüs ...21, 72 Hepatitis A/Hepatit A ... 94

Hepatitis B virus/Hepatit B virüs ...1, 53, 80 Hepatitis B/Hepatit B ...44,85, 94 Hepatitis C virus infection/Hepatitis C virüs enfeksiyonu .. 40

Hepatitis C/Hepatit C ... 38, 62, 65, 94 Hepatitis D virus/Hepatit D virüs ... 80

Hepatitis delta/Delta hepatit ...80, 89 IgG/IgG ...21, 72 IgM/IgM ...21, 72 Immunity/Bağışıklık ... 44

Immunosuppression/İmmünsupresyon ... 56

Inactive carriers/İnaktif taşıyıcılık ... 89

Interferon/İnterferon ...62, 80 Interferons/İnterferonlar ...102

Lamivudine/Lamivudin ...17, 85 Life-cycle/Yaşam-siklusu ... 1

Liver biopsy/Karaciğer biyopsi ... 9

Mean platelet volüme/Ortalama trombosit Hacmi ... 38

Mouse/Fare ... 65

Non-invasive marker/Non-invaziv belirteç ... 9

Occult hepatitis B/Okkült hepatit B ...56, 106 Pegylated interferon alpha 2a/Pegile interferon alfa 2a .. 35

Pegylated interferon alpha/Pegile interferon alfa ... 59

Plasmapheresis/Plazmaferez ... 98

PON1/PON1 ... 13

Pregnancy/Gebelik ... 31

Protease inhibitors/Proteaz inhibitörleri ...102

Rat/Rat ... 65

Reactivation/Reaktivasyon ...48, 56 Repeated tests/Tekrarlanan testler... 76

Replication/Replikasyon ... 1

Resistance/Direnç ... 17

Ribavirin/Ribavirin ... 59

RPR/RPR... 28

Seroprevalance/Seroprevalans ... 24, 31, 72, 94 Sickle cell disease/Orak hücreli anemi ... 98

Skin rash/Deri döküntüsü... 59

Socio-economic/Sosyo-ekonomi ... 24

Sofosbuvir/Sofosbuvir ... 62

Superinfection/Süperenfeksiyon... 80

Telaprevir/Telaprevir ...102

Tenofovir/Tenofovir ... 85

Thrombocytopenia/Trombositopeni...102

Treatment/Tedavi ... 89

Tupaia/Tupaia ... 65

Vitamin D/Vitamin D ... 44

2015 Subject Index

Referanslar

Benzer Belgeler

Bu olgumuzu sunmamızdaki amacımız, yaygın oral tutulumlu bir skuamöz hücreli papillom vakasının cerrahi eksizyon ve sistemik interferon alfa kombi- nasyonu ile tedavi ve

When we compared the pre-treatment HRQoL scores of patients with CHC and controls, we determined statistically significantly lower physical functioning (p=0.006), physical

The rate of HBsAg clearance 3 years after treatment was 2% in HBeAg-positive patients and 5% in HBeAg- negative patients treated with Peg-IFN; the rate of HBsAg loss was 4.6%

In the literature, when concurrent cases with HIV infection are excluded, development of acute pancreatitis is reported in 49 cases due to standard IFN alpha and 5 cases due

First of all, definition of occult hepatitis B virus (OHB) infection is long-lasting presence of hepatitis B virus (HBV) deoxyribonucleic acid (DNA) in the liver with

This study aims to evaluate the pre-treatment and post-treatment ophthalmic findings in chronic hepatitis patients who were given PeG-IFn-α treatment and followed up at the

here, we report a patient with chronic hepatitis B who developed spooning (koilonychia) of the left hand middle fingernail and falling off the right big toe nail during PeG-IFn

According to the guidelines, response probability to interferon treatment in the third month should be evaluated using HBV DNA level measurements, and